SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-003630
Filing Date
2024-02-09
Accepted
2024-02-09 16:07:24
Documents
15
Period of Report
2024-02-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K opk20240209_8k.htm   iXBRL 8-K 24652
  Complete submission text file 0001437749-24-003630.txt   156161

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA opk-20240209.xsd EX-101.SCH 3400
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE opk-20240209_def.xml EX-101.DEF 11420
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE opk-20240209_lab.xml EX-101.LAB 15309
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE opk-20240209_pre.xml EX-101.PRE 11580
16 EXTRACTED XBRL INSTANCE DOCUMENT opk20240209_8k_htm.xml XML 2816
Mailing Address 4400 BISCAYNE BLVD. MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD. MIAMI FL 33137 305-575-4181
OPKO HEALTH, INC. (Filer) CIK: 0000944809 (see all company filings)

IRS No.: 752402409 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33528 | Film No.: 24614847
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)